SCHEMBL8173333

SCHEMBL8173333

COc1ccc2cc(CC3SC(=S)NC3=O)ccc2c1

nearest known ligand 0.66

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CA2 P00918 3/20 0.66
PPARG P37231 6/20 0.48
FFAR1 O14842 3/20 0.48
MPC2 O95563 1/20 0.48
CYP2C8 P10632 1/20 0.48
CYP2C9 P11712 1/20 0.48
PTPN1 P18031 1/20 0.45
MEN1 O00255 1/20 0.43
RAB9A P51151 1/20 0.43
KMT2A Q03164 1/20 0.43
PTGS1 P23219 1/20 0.43
AKR1C3 P42330 1/20 0.43
AKR1C2 P52895 1/20 0.43
ALDH1A1 P00352 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
PPARA Q07869 1/20 0.42
MAOA P21397 1/20 0.42
CISD1 Q9NZ45 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13846731 0.87 CA2 (0.64) CA2PPARGFFAR1MPC2CYP2C8
SCHEMBL8192117 0.86 CA2 (0.64) CA2PPARGFFAR1MPC2CYP2C8
SCHEMBL8173780 0.80 CA2 (0.59) CA2PPARGFFAR1MPC2CYP2C8
SCHEMBL8179494 0.80 CA2 (0.81) CA2PPARGMPC2CYP2C8CYP2C9
SCHEMBL8177729 0.79 CA2 (0.57) CA2FFAR1MEN1RAB9AKMT2A
SCHEMBL8187284 0.79 CA2 (0.72) CA2PPARGMPC2CYP2C8CYP2C9
SCHEMBL8310042 0.76 CA2 (0.56) CA2PPARGFFAR1MPC2CYP2C8
SCHEMBL8178940 0.75 PTPN1 (0.56) CA2PPARGMPC2CYP2C8CYP2C9
SCHEMBL12961220 0.75 CA2 (0.71) CA2PPARGMPC2CYP2C8CYP2C9
SCHEMBL8173454 0.74 CA2 (0.61) CA2PPARGFFAR1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2000018748-A1 RHODANINE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF METABOLIC BONE DISORDERS ROCHE DIAGNOSTICS GMBH (DE) 2000-04-06 WO disclosed